Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 
 

Life Sciences

full industries list
Life Sciences Image

Fish attorneys have served as leading advisors to pioneers in the pharmaceutical, biotechnology, and life sciences fields for more than a century. For three consecutive years, we have been named the top US law firm for life sciences and biotechnology IP work by Managing Intellectual Property magazine. Clients choose Fish because of the technical and scientific expertise of our internationally recognized attorneys.

Large and small companies, along with academic and research institutions, turn to Fish’s team to protect their most valuable innovations. We offer biotechnology and pharmaceutical clients services that include:

  • Patent portfolio planning, strategic advice, opinions, and prosecution
  • Patent reexamination advice
  • Litigation services, including representation in Hatch-Waxman cases
  • FDA expertise
  • Counsel on licensing and other transactions

We have a rapidly expanding practice representing branded pharmaceutical companies in Hatch-Waxman litigation. Biotechnology and pharmaceutical companies trust Fish’s litigation team to handle these complicated, high-stakes cases because we are the world’s most experienced patent litigators.

Examples of our biotechnology and pharmaceutical work include:

  • Representing dozens of biotechnology and pharmaceutical clients in patent infringement litigation
  • Successfully litigating ANDA cases on behalf of branded pharmaceuticals
  • Obtaining patents for therapeutic agents and methods currently in clinical trials, including tumor-specific agents such as oncolytics viruses and humanized antibodies and methods for treating strokes
  • Patenting groundbreaking tissue engineering patents on breakthroughs that show promise in treating spinal cord injuries
  • Obtaining the first patent on a genetically engineered animal
  • Gaining FDA approvals for small molecule drugs and biologics, including gene and cell therapies, antibiotics, immunologics, and anti-anxiety medications
  • Conducting intellectual property due diligence on thousands of licensing agreements for the merger of two large pharmaceuticals companies in just a few months’ time

Search Fish Team

Search by Letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
No matches
Life Sciences

Life Sciences Team

What's Trending in Life Sciences

Filter by
News
April 6, 2015
Post-Approval Conduct and the Hatch-Waxman Safe Harbor
Articles
News
March 9, 2015
FDA Approves First Biosimilar Drug for U.S.
Articles
Media Coverage
News
February 25, 2015
Pharmaceutical Trademarks 2015/2016: A Global Guide
Articles
News
February 18, 2015
Fish’s Terry Mahn Quoted in Bloomberg BNA’s Pharmaceutical Law & Industry Report “Takeda, Colcrys Investors Appeal Ruling Upholding FDA’s Approval of Competing Drug”
Articles
News
February 6, 2015
FDA Issues Final Guidance Documents on Medical Device Data Systems and Mobile Medical Applications
Client Alerts
News
January 26, 2015
FDA’s Draft ‘Wellness’ Guidance Potentially Expands the Universe of Unregulated Products
Articles
News
January 26, 2015
The BPCIA “Patent Dance”–Waiting for the Music to Begin
Articles
News
January 23, 2015
Fish’s Terry Mahn Quoted in Bloomberg BNA’s Pharmaceutical Law & Industry Report “Biosimilars Policy, Accelerating Medical Breakthroughs Among Year’s Key Topics”
Articles
News
January 20, 2015
John Dragseth Identifies “Top 5 Software-Patenting Issues for Life Sciences Companies” in Law360
Articles
Media Coverage
News
January 8, 2015
USPTO Guidance on Natural Product Development
Articles
News
December 30, 2014
Bulletproofing Pharma Patents
Articles
News
December 29, 2014
Fish’s Terry Mahn Quoted in Bloomberg BNA’s Daily Report for Executives, “Inexplicable Delays by DEA Regulators Imperil Only Known Test for Parkinson's”
Media Coverage
load more topics